Image

Multi-Omics for Maternal Health After Preeclampsia

Recruiting
18 - 50 years of age
Female
Phase N/A

Powered by AI

Overview

To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.

Description

We will recruit and retain a diverse population of pregnant women who are high- and low-risk for hypertensive disorders of pregnancy/preeclampsia (HDP/PE) for longitudinal collection of phenotypic and environmental exposure measures and biosamples for integrative analysis of phenotypic, environmental, and multi-omic data to understand links between development of HDP/PE and associated fetal pathologies during pregnancy, as well as postpartum maternal health. Participation in the study will begin no later than the second trimester of pregnancy (enrollment by 24 weeks of gestation) and continue through the first year postpartum. Over the course of the study, biospecimens and relevant surveys and cardiovascular assessments will be collected at specified intervals/time-points, as outlined in the table below. In-person study visits should take no more than 30 minutes. Relevant medical information collected as part of routine clinical care will be obtained from the electronic medical record (EMR). The study will take place at UCSD and VUMC prenatal clinics and hospital labor and delivery units, or another private location of the participants choosing, such as their home or office.

Eligibility

Inclusion Criteria:

  • Pregnant women 18 years of age to 50 years of age
  • 10-24 weeks gestation at time of enrollment
  • Singleton pregnancy
  • Planning to deliver at a study site (UCSD or VUMC)

Exclusion Criteria:

  • Inability to give informed consent
  • Intrauterine fetal demise
  • Fetal genetic or structural anomaly
  • Institutionalization for psychiatric disorder, mental deficiency or incarcerated
  • Active or history of malignancy requiring major surgery or systemic chemotherapy
  • Multi-fetal gestation or a twin demise at any gestational age
  • Known maternal or fetal chromosomal anomalies
  • Patients who plan to keep their placenta after delivery

Study details

Pre-Eclampsia, Pregnancy Induced Hypertension

NCT06340152

University of California, San Diego

16 April 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.